Related Experiment Video

Updated: Jun 1, 2026

Isolation of Lung Retinoid-Containing Cells by Cell Sorting
07:47

Isolation of Lung Retinoid-Containing Cells by Cell Sorting

Published on: April 11, 2025

Alpha-1-antitrypsin deficiency in early childhood

Aleksandra Topic1, Dragan Prokic, Ivica Stankovic

  • 1University of Belgrade, Faculty of Pharmacy, Institute of Medical Biochemistry, Belgrade, Serbia. aleksandra.topic1@gmail.com

Fetal and Pediatric Pathology
|May 26, 2011
PubMed

Insights

Alpha-1-antitrypsin deficiency (AATD) is often missed in children with liver issues. Early screening for AATD in infants with liver dysfunction is crucial for timely diagnosis and management.

Area of Science:

  • Pediatrics
  • Hepatology
  • Medical Genetics

Background:

  • Alpha-1-antitrypsin deficiency (AATD) is an inherited disorder that can lead to severe liver disease in children.
  • AATD is frequently undiagnosed in pediatric populations presenting with liver dysfunction.

Purpose of the Study:

  • To determine the prevalence of severe and moderate AATD in infants with liver dysfunction.
  • To identify clinical and histological differences between severe and moderate AATD in this cohort.
  • To assess the utility of diagnostic markers in identifying AATD in infants.

Main Methods:

  • 161 infants with liver dysfunction underwent isoelectric focusing for AATD screening.
  • Liver biopsies were evaluated using PAS-D staining and immunohistochemistry.
  • Clinical data including bilirubin levels, liver size, and birth weight were analyzed.

Main Results:

  • AATD was detected in 14.7% (severe) and 12.2% (moderate) of infants.
  • Severe AATD cases showed significantly higher frequencies of cholestasis, hepatomegaly, splenomegaly, and elevated transaminases compared to moderate AATD.
  • Histological findings like portal inflammation and fibrosis were common in both AATD groups.

Conclusions:

  • Early screening for AATD in infants with liver dysfunction is essential for accurate diagnosis.
  • Distinct clinical and histological features can help differentiate between severe and moderate AATD.
  • Diagnostic markers, particularly immunohistochemistry, play a vital role in identifying AATD in at-risk infants.

More Related Videos

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...